首页 > 最新文献

Seminars in Ophthalmology最新文献

英文 中文
Lacrimal History - Part 36: Doyens of Dacryology Series - Michael McDonogh.
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-22 DOI: 10.1080/08820538.2025.2452088
Mohammad Javed Ali, Peter John Wormald
{"title":"Lacrimal History - Part 36: Doyens of Dacryology Series - Michael McDonogh.","authors":"Mohammad Javed Ali, Peter John Wormald","doi":"10.1080/08820538.2025.2452088","DOIUrl":"https://doi.org/10.1080/08820538.2025.2452088","url":null,"abstract":"","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-2"},"PeriodicalIF":1.9,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024437","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asymmetric Intraocular Pressure Changes in Dominant and Contralateral Eyes: The Dark Room Prone Provocative Test.
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-22 DOI: 10.1080/08820538.2024.2443972
Junwei Wang, Jun Wang, Tsz Kin Ng, Chukai Huang

Purpose: To evaluate changes in intraocular pressure (IOP) in dominant and contralateral eyes following the dark room prone provocative test (DRPPT) in the study subjects with shallow anterior chamber.

Methods: This was a prospective, single-center, non-randomized controlled trial of 43 subjects (86 eyes) with shallow anterior chamber. The dominant eye was identified using the card-hole method. The study subjects underwent the DRPPT for one hour. Pre- and post-DRPPT IOP was measured using an I-Care tonometer, and pupillary parameters, including amplitude of constriction, peak constriction velocity, and peak re-dilation velocity, were also measured using the RAPDx® dynamic pupillometer.

Results: Significant increases in IOP were observed in both the dominant and contralateral eyes after DRPPT, compared to their respective pre-DRPPT IOP levels. (p < .01). Moreover, IOP variation before and after DRPPT was significantly greater in the dominant eye than in the contralateral eye (median 3.60 mmHg vs. 2.70 mmHg, p < .05). The dominant eyes exhibited a smaller amplitude of constriction (1.07 ± 0.35 mm vs 1.14 ± 0.34 mm, P < .05) and slower constriction velocity (3.71 ± 1.12 mm/s vs 3.78 ± 1.11 mm/s, P < .05) as compared to the contralateral eyes.

Conclusions: This study demonstrated that the dominant eye exhibited greater IOP changes after DRPPT than the contralateral eye. Additionally, it showed smaller pupil constriction and slower contraction, indicating a higher likelihood of pupil blockage in the dominant eye with shallow anterior chambers. This asymmetry partially explains the monocular onset of acute angle-closure attacks.

{"title":"Asymmetric Intraocular Pressure Changes in Dominant and Contralateral Eyes: The Dark Room Prone Provocative Test.","authors":"Junwei Wang, Jun Wang, Tsz Kin Ng, Chukai Huang","doi":"10.1080/08820538.2024.2443972","DOIUrl":"https://doi.org/10.1080/08820538.2024.2443972","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate changes in intraocular pressure (IOP) in dominant and contralateral eyes following the dark room prone provocative test (DRPPT) in the study subjects with shallow anterior chamber.</p><p><strong>Methods: </strong>This was a prospective, single-center, non-randomized controlled trial of 43 subjects (86 eyes) with shallow anterior chamber. The dominant eye was identified using the card-hole method. The study subjects underwent the DRPPT for one hour. Pre- and post-DRPPT IOP was measured using an I-Care tonometer, and pupillary parameters, including amplitude of constriction, peak constriction velocity, and peak re-dilation velocity, were also measured using the RAPDx® dynamic pupillometer.</p><p><strong>Results: </strong>Significant increases in IOP were observed in both the dominant and contralateral eyes after DRPPT, compared to their respective pre-DRPPT IOP levels. (<i>p</i> < .01). Moreover, IOP variation before and after DRPPT was significantly greater in the dominant eye than in the contralateral eye (median 3.60 mmHg vs. 2.70 mmHg, <i>p</i> < .05). The dominant eyes exhibited a smaller amplitude of constriction (1.07 ± 0.35 mm vs 1.14 ± 0.34 mm, P < .05) and slower constriction velocity (3.71 ± 1.12 mm/s vs 3.78 ± 1.11 mm/s, P < .05) as compared to the contralateral eyes.</p><p><strong>Conclusions: </strong>This study demonstrated that the dominant eye exhibited greater IOP changes after DRPPT than the contralateral eye. Additionally, it showed smaller pupil constriction and slower contraction, indicating a higher likelihood of pupil blockage in the dominant eye with shallow anterior chambers. This asymmetry partially explains the monocular onset of acute angle-closure attacks.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-7"},"PeriodicalIF":1.9,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143024395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Complications After Incisional/Excisional Minimally Invasive Glaucoma Surgery-An Update and Literature Review. 切口/切除微创青光眼手术后的并发症——最新进展及文献综述。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-20 DOI: 10.1080/08820538.2025.2450687
Aparna Rao, Manikanta Damagantla, Rashmi Krishnamurthy, Sirisha Senthil

Purpose: To discuss comprehensively the varied complications after stent-less incisional or excisional minimally invasive glaucoma surgery (MIGS).

Method: A review of reported complications after stent-less MIGS procedures including gonioscopy-assisted transluminal trabeculotomy (GATT), bent needle goniectomy (BANG), Kahook-dual blade goniotomy, and microincisional trabeculectomy (MIT) published between 2014-2024, were analyzed and summarized.

Results: Apart from hyphema, peripheral anterior synechiae, and intraocular pressure spikes, other vision-threatening complications like cyclodialysis, Descemet's detachment, corneal edema, iridodilalysis, vitreous loss or vitreous hemorrhage can also occur intra- or postoperatively after any incisional or excisional MIGS procedures.

Conclusion: All possible complications are to be kept in mind during MIGS despite the procedures being minimally invasive. Adequate care should be taken during different stages of the surgery to avoid these complications.

目的:全面探讨无支架微创青光眼手术(MIGS)术后各种并发症。方法:回顾2014-2024年间报道的无支架MIGS手术的并发症,包括经腔内镜检辅助的小梁切开术(GATT)、弯针性骨切除术(BANG)、kahook -双刀性骨切开术和微切口小梁切除术(MIT)。结果:除了前体积血、周围前粘连和眼压峰值外,其他威胁视力的并发症,如睫状体透析、Descemet脱离、角膜水肿、虹膜破裂、玻璃体丢失或玻璃体出血,也可能在任何切口或切除的MIGS手术中或术后发生。结论:尽管MIGS手术是微创手术,但仍应注意所有可能的并发症。在手术的不同阶段应注意避免这些并发症。
{"title":"Complications After Incisional/Excisional Minimally Invasive Glaucoma Surgery-An Update and Literature Review.","authors":"Aparna Rao, Manikanta Damagantla, Rashmi Krishnamurthy, Sirisha Senthil","doi":"10.1080/08820538.2025.2450687","DOIUrl":"https://doi.org/10.1080/08820538.2025.2450687","url":null,"abstract":"<p><strong>Purpose: </strong>To discuss comprehensively the varied complications after stent-less incisional or excisional minimally invasive glaucoma surgery (MIGS).</p><p><strong>Method: </strong>A review of reported complications after stent-less MIGS procedures including gonioscopy-assisted transluminal trabeculotomy (GATT), bent needle goniectomy (BANG), Kahook-dual blade goniotomy, and microincisional trabeculectomy (MIT) published between 2014-2024, were analyzed and summarized.</p><p><strong>Results: </strong>Apart from hyphema, peripheral anterior synechiae, and intraocular pressure spikes, other vision-threatening complications like cyclodialysis, Descemet's detachment, corneal edema, iridodilalysis, vitreous loss or vitreous hemorrhage can also occur intra- or postoperatively after any incisional or excisional MIGS procedures.</p><p><strong>Conclusion: </strong>All possible complications are to be kept in mind during MIGS despite the procedures being minimally invasive. Adequate care should be taken during different stages of the surgery to avoid these complications.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-7"},"PeriodicalIF":1.9,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143011060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Readership Awareness Series - Paper 15: How the ICMJE 2025 Recommendations Update Impact the Scientific Community? 读者意识系列-论文15:ICMJE 2025建议更新如何影响科学界?
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-18 DOI: 10.1080/08820538.2025.2454851
Mohammad Javed Ali, Ali Djalilian
{"title":"Readership Awareness Series - Paper 15: How the ICMJE 2025 Recommendations Update Impact the Scientific Community?","authors":"Mohammad Javed Ali, Ali Djalilian","doi":"10.1080/08820538.2025.2454851","DOIUrl":"https://doi.org/10.1080/08820538.2025.2454851","url":null,"abstract":"","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-2"},"PeriodicalIF":1.9,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143011065","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-Level Red Light for the Progression Myopia in Children: A Meta-Analysis. 低水平红灯对儿童进展性近视的影响:一项meta分析。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-18 DOI: 10.1080/08820538.2025.2452885
Xian Yang, Lin Yao, Gang Sun, Haoyan Zhang, Haolin Yu, Haiqing Bai

Purposes: This meta-analysis aims to systematically analyze the efficacy of low-level red light (LRL) therapy for myopia control and prevention in children.

Methods: All the data were searched from the PubMed, EMBASE, and the Cochrane Library. The Cochrane Handbook was used to evaluate the quality of the included studies. Additionally, this meta-analysis was performed by using the Revman 5.4 software. Inclusion criteria was randomized controlled trials (RCTs), and the patient populations were younger than 18 years.

Results: Eight RCTs were included in this study. Compared with control group, LRL treatment could reduce the progression in spherical equivalent refractive (SER) for myopia children (MD, 0.49; 95% CI, 0.27 to 0.71; p < .00001). Also, less change in axial length (AL) and increase in subfoveal choroid thickness (SFCT) was shown in the LRL group for both myopia and premyopia children (MD, -0.24, 28.16; 95% CI, -0.32 to -0.17, 18.78 to 37.55; p < .00001, respectively).

Conclusion: Our meta-analysis shows that LRL therapy could delay the refraction progression of myopia children. It also could reduce progression in axial length and SFCT thinning in both myopia and premoypia children.

目的:本荟萃分析旨在系统分析低水平红光(LRL)治疗对儿童近视控制和预防的效果。方法:所有资料均从PubMed、EMBASE和Cochrane图书馆检索。使用Cochrane手册评估纳入研究的质量。采用Revman 5.4软件进行meta分析。纳入标准为随机对照试验(rct),患者年龄小于18岁。结果:本研究纳入8项随机对照试验。与对照组相比,LRL治疗可减少近视儿童球等效屈光(SER)的进展(MD, 0.49;95% CI, 0.27 ~ 0.71;结论:我们的荟萃分析显示,LRL治疗可以延缓近视儿童的屈光进展。它还可以减少近视和弱视儿童的眼轴长度和SFCT变薄的进展。
{"title":"Low-Level Red Light for the Progression Myopia in Children: A Meta-Analysis.","authors":"Xian Yang, Lin Yao, Gang Sun, Haoyan Zhang, Haolin Yu, Haiqing Bai","doi":"10.1080/08820538.2025.2452885","DOIUrl":"https://doi.org/10.1080/08820538.2025.2452885","url":null,"abstract":"<p><strong>Purposes: </strong>This meta-analysis aims to systematically analyze the efficacy of low-level red light (LRL) therapy for myopia control and prevention in children.</p><p><strong>Methods: </strong>All the data were searched from the PubMed, EMBASE, and the Cochrane Library. The Cochrane Handbook was used to evaluate the quality of the included studies. Additionally, this meta-analysis was performed by using the Revman 5.4 software. Inclusion criteria was randomized controlled trials (RCTs), and the patient populations were younger than 18 years.</p><p><strong>Results: </strong>Eight RCTs were included in this study. Compared with control group, LRL treatment could reduce the progression in spherical equivalent refractive (SER) for myopia children (MD, 0.49; 95% CI, 0.27 to 0.71; <i>p</i> < .00001). Also, less change in axial length (AL) and increase in subfoveal choroid thickness (SFCT) was shown in the LRL group for both myopia and premyopia children (MD, -0.24, 28.16; 95% CI, -0.32 to -0.17, 18.78 to 37.55; <i>p</i> < .00001, respectively).</p><p><strong>Conclusion: </strong>Our meta-analysis shows that LRL therapy could delay the refraction progression of myopia children. It also could reduce progression in axial length and SFCT thinning in both myopia and premoypia children.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-6"},"PeriodicalIF":1.9,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143011063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Pediatric Rhegmatogenous Retinal Detachment. 儿童孔源性视网膜脱离的治疗。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-15 DOI: 10.1080/08820538.2024.2440725
Theodore Bowe, Olufemi E Adams, Yoshihiro Yonekawa

Introduction and primary objective: Pediatric rhegmatogenous retinal detachment (RRD) presents unique challenges in diagnosis and management. A thorough evaluation of family, medical, and ocular history is helpful, as systemic and genetic conditions can predispose children to RRD. Trauma, high myopia, and history of prematurity are also common risk factors. Examining young children in the outpatient setting may have limitations, but the yield can be maximized by modifying examination techniques and utilizing imaging technologies. In this manscript, the considerations for diagnosis and management of pediatric rhegmatogenous retinal detachment are outlined.

Conclusions: Primary scleral buckling is the treatment of choice for the vast majority of pediatric RRDs, as it offers a higher single surgery success rate in these young eyes with firmly adherent posterior hyaloid. Primary vitrectomy is not recommended due to this reason. Scleral buckling is the mainstay of pediatric RRD surgery, even in cases that may typically undergo vitrectomy in adults. Prophylactic treatment of the fellow eye may also be warranted in certain clinical scenarios. Understanding the unique challenges these patients face is important for early diagnosis, timely intervention, and tailored surgical strategies to optimize visual outcomes in this vulnerable patient population.

简介和主要目的:儿童孔源性视网膜脱离(RRD)在诊断和治疗方面提出了独特的挑战。全面评估家庭、医疗和眼部病史是有帮助的,因为系统和遗传条件可使儿童易患RRD。外伤、高度近视和早产史也是常见的危险因素。在门诊环境中检查幼儿可能有局限性,但通过修改检查技术和利用成像技术可以最大限度地提高产量。在这个手稿,考虑的诊断和管理的儿童孔源性视网膜脱离概述。结论:原发性巩膜屈曲是绝大多数儿童rrd的首选治疗方法,因为它在这些具有牢固粘附的后玻璃体的年轻眼睛中提供了更高的单次手术成功率。由于这个原因,不建议进行初级玻璃体切除术。巩膜屈曲是儿童RRD手术的主要方法,即使在成人中可能需要进行玻璃体切除术的情况下也是如此。在某些临床情况下,对同侧眼进行预防性治疗也是必要的。了解这些患者面临的独特挑战对于早期诊断,及时干预和定制手术策略以优化这一弱势患者群体的视力结果非常重要。
{"title":"Management of Pediatric Rhegmatogenous Retinal Detachment.","authors":"Theodore Bowe, Olufemi E Adams, Yoshihiro Yonekawa","doi":"10.1080/08820538.2024.2440725","DOIUrl":"https://doi.org/10.1080/08820538.2024.2440725","url":null,"abstract":"<p><strong>Introduction and primary objective: </strong>Pediatric rhegmatogenous retinal detachment (RRD) presents unique challenges in diagnosis and management. A thorough evaluation of family, medical, and ocular history is helpful, as systemic and genetic conditions can predispose children to RRD. Trauma, high myopia, and history of prematurity are also common risk factors. Examining young children in the outpatient setting may have limitations, but the yield can be maximized by modifying examination techniques and utilizing imaging technologies. In this manscript, the considerations for diagnosis and management of pediatric rhegmatogenous retinal detachment are outlined.</p><p><strong>Conclusions: </strong>Primary scleral buckling is the treatment of choice for the vast majority of pediatric RRDs, as it offers a higher single surgery success rate in these young eyes with firmly adherent posterior hyaloid. Primary vitrectomy is not recommended due to this reason. Scleral buckling is the mainstay of pediatric RRD surgery, even in cases that may typically undergo vitrectomy in adults. Prophylactic treatment of the fellow eye may also be warranted in certain clinical scenarios. Understanding the unique challenges these patients face is important for early diagnosis, timely intervention, and tailored surgical strategies to optimize visual outcomes in this vulnerable patient population.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-5"},"PeriodicalIF":1.9,"publicationDate":"2025-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143011064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epidemiology of Consumer Product-Related Ocular Injuries in the Incarcerated Population. 监禁人群中消费品相关眼部损伤的流行病学研究。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-09 DOI: 10.1080/08820538.2025.2450685
David Mothy, Hassaam S Choudhry, Aneesh P Reddy, Mohammad H Dastjerdi

Purpose: To characterize the epidemiology of consumer product-related ocular injury in the United States (US) incarcerated population, and identify preventable causes.

Methods: The National Electronic Injury Surveillance System (NEISS) database was queried for cases of eye injury from 2014 to 2023. Incarcerated cases were identified using the keywords "prison", "jail", "inmate", and "incarcerate". Year of injury, diagnosis, product code, and demographic information were gathered and compared between the incarcerated and general US populations using SPSS version 29 (IBM Corp.). A narrative analysis categorized cases of ocular trauma in the incarcerated by common causes of injury.

Results: Between 2014 and 2023, there were an estimated 1,644,841 cases of consumer-product related ocular injury the US, with 2683 cases occurring in the incarcerated. A higher percentage of ocular injury cases in the incarcerated involved African American individuals (43.42% vs. 17.18%), males (92.22% vs 68.54%), alcohol use (4.11% vs. 0.64%), drug use (3.91% vs. 0.82%), and hospitalization (4.96% vs. 1.39%). Contusions were less common in the incarcerated population (27.21% vs. 41.31%), while foreign body injuries were more common (24.38% vs. 18.75%). Penal labor, including cleaning (13.74%), welding (8.25%), yardwork (5.92%), and power grinding (5.72%), accounted for 36.36% of injuries. 26.50% of injuries were sports-related, with basketball involved in 16.82%.

Conclusions: The epidemiology of ocular injury in the incarcerated differs from the general US population. Penal labor and sports-related ocular injury represent a majority of cases, underscoring the need for protective eyewear.

目的:研究美国监禁人群中消费品相关眼部损伤的流行病学特征,并确定可预防的原因。方法:查询国家电子伤害监测系统(NEISS)数据库2014 - 2023年眼部损伤病例。使用关键词“监狱”、“监狱”、“囚犯”和“监禁”来识别被监禁的案件。使用SPSS version 29 (IBM Corp.)收集并比较了监禁人群和普通美国人群的受伤年份、诊断、产品代码和人口统计信息。叙述分析分类的情况下,眼外伤在监禁的常见原因的伤害。结果:2014年至2023年间,美国估计有1,644,841例与消费品相关的眼部损伤,其中2683例发生在监禁中。非裔美国人(43.42%对17.18%)、男性(92.22%对68.54%)、酒精使用(4.11%对0.64%)、药物使用(3.91%对0.82%)和住院(4.96%对1.39%)的眼部损伤病例比例较高。监禁人群中挫伤较少见(27.21%比41.31%),而异物损伤较常见(24.38%比18.75%)。刑事劳动,包括清洁(13.74%),焊接(8.25%),庭院工作(5.92%)和动力研磨(5.72%),占伤害的36.36%。26.50%的受伤与运动有关,其中16.82%与篮球有关。结论:被监禁者眼部损伤的流行病学与美国一般人群不同。刑罚劳动和运动相关的眼部损伤代表了大多数情况下,强调需要保护眼镜。
{"title":"Epidemiology of Consumer Product-Related Ocular Injuries in the Incarcerated Population.","authors":"David Mothy, Hassaam S Choudhry, Aneesh P Reddy, Mohammad H Dastjerdi","doi":"10.1080/08820538.2025.2450685","DOIUrl":"https://doi.org/10.1080/08820538.2025.2450685","url":null,"abstract":"<p><strong>Purpose: </strong>To characterize the epidemiology of consumer product-related ocular injury in the United States (US) incarcerated population, and identify preventable causes.</p><p><strong>Methods: </strong>The National Electronic Injury Surveillance System (NEISS) database was queried for cases of eye injury from 2014 to 2023. Incarcerated cases were identified using the keywords \"prison\", \"jail\", \"inmate\", and \"incarcerate\". Year of injury, diagnosis, product code, and demographic information were gathered and compared between the incarcerated and general US populations using SPSS version 29 (IBM Corp.). A narrative analysis categorized cases of ocular trauma in the incarcerated by common causes of injury.</p><p><strong>Results: </strong>Between 2014 and 2023, there were an estimated 1,644,841 cases of consumer-product related ocular injury the US, with 2683 cases occurring in the incarcerated. A higher percentage of ocular injury cases in the incarcerated involved African American individuals (43.42% vs. 17.18%), males (92.22% vs 68.54%), alcohol use (4.11% vs. 0.64%), drug use (3.91% vs. 0.82%), and hospitalization (4.96% vs. 1.39%). Contusions were less common in the incarcerated population (27.21% vs. 41.31%), while foreign body injuries were more common (24.38% vs. 18.75%). Penal labor, including cleaning (13.74%), welding (8.25%), yardwork (5.92%), and power grinding (5.72%), accounted for 36.36% of injuries. 26.50% of injuries were sports-related, with basketball involved in 16.82%.</p><p><strong>Conclusions: </strong>The epidemiology of ocular injury in the incarcerated differs from the general US population. Penal labor and sports-related ocular injury represent a majority of cases, underscoring the need for protective eyewear.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-6"},"PeriodicalIF":1.9,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954488","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors for Extraocular Relapse in Retinoblastoma. 视网膜母细胞瘤眼外复发的危险因素。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-09 DOI: 10.1080/08820538.2025.2450682
Rosario Aschero, Margarida Simao, Jaume Catala-Mora, Guillermo L Chantada

Background: Metastatic retinoblastoma remains a significant challenge in pediatric oncology, with stark disparities in survival outcomes between high-income countries (HICs) and low-income countries (LICs). Delayed diagnosis and treatment, driven by socioeconomic factors and limitations in healthcare systems, contribute to poorer outcomes in LICs. Histopathological characteristics, including high-risk pathology factors (HRPFs) and the extent of ocular tumor invasion, are critical for predicting metastatic risk and guiding treatment strategies.

Methods: This review examines the role of clinical, histopathological, and molecular characteristics in assessing metastatic risk in retinoblastoma. Literature on HRPFs, tumor invasion, and molecular subtypes was analyzed to understand their impact on risk stratification and therapy optimization, particularly in resource-limited settings.

Results: Retinoblastoma is increasingly recognized as a heterogeneous disease with at least two distinct molecular subtypes. High-risk cases frequently exhibit genetic alterations that underscore the need to incorporate molecular profiling into risk assessment. Current adjuvant therapy approaches, however, vary widely, and debates persist regarding their necessity based on tumor characteristics. Integrated strategies that combine clinical, histopathological, and molecular data show promise in improving management and survival outcomes.

Conclusions: Addressing the disparities in metastatic retinoblastoma outcomes requires a multifaceted approach. By integrating clinical, histopathological, and molecular insights, management strategies can be optimized to improve survival, particularly in resource-limited settings where challenges are most pronounced.

背景:转移性视网膜母细胞瘤仍然是儿科肿瘤学的一个重大挑战,在高收入国家(HICs)和低收入国家(lic)之间的生存结果存在明显差异。由于社会经济因素和卫生保健系统的局限性,导致诊断和治疗延误,导致低收入国家的预后较差。组织病理学特征,包括高危病理因素(HRPFs)和眼部肿瘤的侵袭程度,对于预测转移风险和指导治疗策略至关重要。方法:本文综述了临床、组织病理学和分子特征在评估视网膜母细胞瘤转移风险中的作用。我们分析了有关HRPFs、肿瘤侵袭和分子亚型的文献,以了解它们对风险分层和治疗优化的影响,特别是在资源有限的情况下。结果:视网膜母细胞瘤越来越被认为是一种异质性疾病,至少有两种不同的分子亚型。高危病例经常表现出基因改变,这强调了将分子谱分析纳入风险评估的必要性。然而,目前的辅助治疗方法差异很大,关于它们基于肿瘤特征的必要性的争论仍然存在。结合临床、组织病理学和分子数据的综合策略有望改善治疗和生存结果。结论:解决转移性视网膜母细胞瘤预后的差异需要多方面的方法。通过整合临床、组织病理学和分子的见解,可以优化管理策略以提高生存率,特别是在资源有限、挑战最明显的环境中。
{"title":"Risk Factors for Extraocular Relapse in Retinoblastoma.","authors":"Rosario Aschero, Margarida Simao, Jaume Catala-Mora, Guillermo L Chantada","doi":"10.1080/08820538.2025.2450682","DOIUrl":"10.1080/08820538.2025.2450682","url":null,"abstract":"<p><strong>Background: </strong>Metastatic retinoblastoma remains a significant challenge in pediatric oncology, with stark disparities in survival outcomes between high-income countries (HICs) and low-income countries (LICs). Delayed diagnosis and treatment, driven by socioeconomic factors and limitations in healthcare systems, contribute to poorer outcomes in LICs. Histopathological characteristics, including high-risk pathology factors (HRPFs) and the extent of ocular tumor invasion, are critical for predicting metastatic risk and guiding treatment strategies.</p><p><strong>Methods: </strong>This review examines the role of clinical, histopathological, and molecular characteristics in assessing metastatic risk in retinoblastoma. Literature on HRPFs, tumor invasion, and molecular subtypes was analyzed to understand their impact on risk stratification and therapy optimization, particularly in resource-limited settings.</p><p><strong>Results: </strong>Retinoblastoma is increasingly recognized as a heterogeneous disease with at least two distinct molecular subtypes. High-risk cases frequently exhibit genetic alterations that underscore the need to incorporate molecular profiling into risk assessment. Current adjuvant therapy approaches, however, vary widely, and debates persist regarding their necessity based on tumor characteristics. Integrated strategies that combine clinical, histopathological, and molecular data show promise in improving management and survival outcomes.</p><p><strong>Conclusions: </strong>Addressing the disparities in metastatic retinoblastoma outcomes requires a multifaceted approach. By integrating clinical, histopathological, and molecular insights, management strategies can be optimized to improve survival, particularly in resource-limited settings where challenges are most pronounced.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-11"},"PeriodicalIF":1.9,"publicationDate":"2025-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954503","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain MRI Screening for Bilateral Retinoblastoma Patients. 双侧视网膜母细胞瘤患者的MRI筛查。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-08 DOI: 10.1080/08820538.2025.2450681
Ronald Hershcovici, Shahar Frenkel, Gal Goldstein, Jacob Pe'er, Maya Eiger-Moscovich

Purpose: Trilateral retinoblastoma (TRB), intracranial neoplasm in heritable retinoblastoma patients, is a very rare fatal disease. Many ocular oncology centers conduct routine screening of retinoblastoma patients by brain imaging. Nevertheless, there is a debate regarding its ability to prolong TRB patients' survival and the number-needed-to-treat. We recommend baseline screening brain imaging in bilateral retinoblastoma patients, followed by imaging according to clinical need. We aim to see if this screening schedule has an impact on patients' survival.

Methods: In a retrospective observational study, we reviewed the medical records of patients diagnosed with bilateral retinoblastoma at a tertiary medical center ocular oncology unit between 1.7.1986 and 1.2.2020, who had at least 36 months follow-up or retinoblastoma-related death. We collected data on patients' demographics, clinical features, systemic evaluation, treatment, follow-up, and outcome.

Results: The analysis included 109 patients, 60 males and 49 females, diagnosed with bilateral retinoblastoma at a median age of 7.0 months (range 0.43-70.5 months). Germline mutation was found in 43 patients (39.4%) and somatic mutation in 15 patients (13.8%). Genetic status was not recorded in 51 patients (46.8%). Fifty-eight patients (53.0%) underwent baseline brain imaging (MRI in 42 patients and CT scan in 16 patients), in all of whom it was within normal limits. During a median follow-up of 138 months (range 19-787 months), 35 children had follow-up brain imaging (MRI in 25 patients and CT in 10 patients). One patient developed symptomatic TRB during follow-up, and is alive and disease-free (0.9%, Cl:0.02%-5.6%). Looking at survival, six patients (5.5%) developed metastatic disease, and eight patients (7.3%) expired, in all of whom death was retinoblastoma-related.

Conclusions: Due to TRB rarity, routine screening by baseline brain MRI may be sufficient, avoiding anesthesia, expenses, distress, and unnecessary interventions, without a significant impact on patients' survival. Nevertheless, due to TRB fatality and treatment morbidity, periodic brain MRI until age 3 is a legitimate option.

目的:三边视网膜母细胞瘤(TRB)是遗传性视网膜母细胞瘤患者的颅内肿瘤,是一种非常罕见的致命性疾病。许多眼科肿瘤中心通过脑成像对视网膜母细胞瘤患者进行常规筛查。然而,关于其延长TRB患者生存的能力和需要治疗的数量存在争议。我们建议对双侧视网膜母细胞瘤患者进行基线筛查脑成像,然后根据临床需要进行影像学检查。我们的目标是看看这个筛查计划是否对患者的生存有影响。方法:回顾性观察1986年7月1日至2020年2月1日在某三级医疗中心眼科肿瘤科诊断为双侧视网膜母细胞瘤的患者,随访至少36个月或视网膜母细胞瘤相关死亡。我们收集了患者的人口统计学、临床特征、系统评估、治疗、随访和结果的数据。结果:本研究纳入109例双侧视网膜母细胞瘤患者,其中男性60例,女性49例,中位年龄7.0个月(范围0.43-70.5个月)。生殖系突变43例(39.4%),体细胞突变15例(13.8%)。51例(46.8%)患者未记录遗传状况。58例患者(53.0%)接受了基线脑成像(42例MRI和16例CT扫描),所有患者均在正常范围内。在中位随访138个月(范围19-787个月)期间,35名儿童进行了随访脑成像(25例MRI, 10例CT)。1例患者在随访期间出现症状性TRB,存活且无病(0.9%,Cl:0.02%-5.6%)。观察生存期,6名患者(5.5%)发展为转移性疾病,8名患者(7.3%)死亡,所有死亡均与视网膜母细胞瘤相关。结论:由于TRB罕见,常规脑MRI基线筛查可能足够,避免麻醉、费用、痛苦和不必要的干预,对患者的生存无显著影响。然而,由于TRB的致死率和治疗发病率,在3岁之前定期进行脑MRI是一个合理的选择。
{"title":"Brain MRI Screening for Bilateral Retinoblastoma Patients.","authors":"Ronald Hershcovici, Shahar Frenkel, Gal Goldstein, Jacob Pe'er, Maya Eiger-Moscovich","doi":"10.1080/08820538.2025.2450681","DOIUrl":"https://doi.org/10.1080/08820538.2025.2450681","url":null,"abstract":"<p><strong>Purpose: </strong>Trilateral retinoblastoma (TRB), intracranial neoplasm in heritable retinoblastoma patients, is a very rare fatal disease. Many ocular oncology centers conduct routine screening of retinoblastoma patients by brain imaging. Nevertheless, there is a debate regarding its ability to prolong TRB patients' survival and the number-needed-to-treat. We recommend baseline screening brain imaging in bilateral retinoblastoma patients, followed by imaging according to clinical need. We aim to see if this screening schedule has an impact on patients' survival.</p><p><strong>Methods: </strong>In a retrospective observational study, we reviewed the medical records of patients diagnosed with bilateral retinoblastoma at a tertiary medical center ocular oncology unit between 1.7.1986 and 1.2.2020, who had at least 36 months follow-up or retinoblastoma-related death. We collected data on patients' demographics, clinical features, systemic evaluation, treatment, follow-up, and outcome.</p><p><strong>Results: </strong>The analysis included 109 patients, 60 males and 49 females, diagnosed with bilateral retinoblastoma at a median age of 7.0 months (range 0.43-70.5 months). Germline mutation was found in 43 patients (39.4%) and somatic mutation in 15 patients (13.8%). Genetic status was not recorded in 51 patients (46.8%). Fifty-eight patients (53.0%) underwent baseline brain imaging (MRI in 42 patients and CT scan in 16 patients), in all of whom it was within normal limits. During a median follow-up of 138 months (range 19-787 months), 35 children had follow-up brain imaging (MRI in 25 patients and CT in 10 patients). One patient developed symptomatic TRB during follow-up, and is alive and disease-free (0.9%, Cl:0.02%-5.6%). Looking at survival, six patients (5.5%) developed metastatic disease, and eight patients (7.3%) expired, in all of whom death was retinoblastoma-related.</p><p><strong>Conclusions: </strong>Due to TRB rarity, routine screening by baseline brain MRI may be sufficient, avoiding anesthesia, expenses, distress, and unnecessary interventions, without a significant impact on patients' survival. Nevertheless, due to TRB fatality and treatment morbidity, periodic brain MRI until age 3 is a legitimate option.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-6"},"PeriodicalIF":1.9,"publicationDate":"2025-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954483","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choroidal Hemangioma Treatment with Propranolol - A Case Study in Sturge-Weber Syndrome and Systematic Literature Review. 心得安治疗脉络膜血管瘤-斯特奇-韦伯综合征一例及系统文献回顾。
IF 1.9 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2025-01-07 DOI: 10.1080/08820538.2025.2450689
Suma Thareja, Elizabeth Lucero, Aparna Ramasubramanian

Purpose: To examine propranolol efficacy in treating diffuse (DCH) and circumscribed choroidal hemangiomas (CCH) and controlling intraocular pressure (IOP) in patients with Sturge-Weber syndrome (SWS).

Methods: A SWS patient case treated with propranolol for DCH is presented. Following PRISMA guidelines, we also performed a systematic review using PubMed/Web of Science, analyzing 14 studies detailing propranolol treatment outcomes for DCH, CCH, and IOP control in SWS. Demographic, clinical, treatment, and outcome data were extracted and statistically analyzed. Fisher's exact test was used to compare findings such as retinal detachment rates.

Results: We reviewed patients treated with propranolol, including 8 DCH, 18 CCH, and 16 SWS cases of IOP control. Retinal detachment rates were significantly higher in DCH compared to CCH cases. Post-propranolol, 73% of DCH and CCH cases showed subretinal fluid improvement, and in SWS patients, 94% had IOP reduction.

Conclusion: This study underscores the potential utility of propranolol beyond its traditional use in cutaneous hemangioma for treatment of CCH/DCH and IOP control.

目的:观察普萘洛尔治疗斯特奇-韦伯综合征(SWS)患者弥漫性(DCH)和局限性脉络膜血管瘤(CCH)及控制眼压(IOP)的疗效。方法:报告1例SWS患者应用心得安治疗DCH。遵循PRISMA指南,我们还使用PubMed/Web of Science进行了系统综述,分析了14项研究,详细介绍了心得安治疗SWS患者DCH、CCH和IOP控制的结果。提取人口学、临床、治疗和结局数据并进行统计分析。Fisher的精确测试被用来比较视网膜脱离率等结果。结果:我们回顾了使用心得安治疗的患者,包括8例DCH, 18例CCH和16例SWS IOP控制。DCH的视网膜脱离率明显高于CCH。服用心得安后,73%的DCH和CCH患者视网膜下积液改善,而在SWS患者中,94%的IOP降低。结论:本研究强调了心得安在皮肤血管瘤治疗CCH/DCH和眼压控制方面的潜在应用价值。
{"title":"Choroidal Hemangioma Treatment with Propranolol - A Case Study in Sturge-Weber Syndrome and Systematic Literature Review.","authors":"Suma Thareja, Elizabeth Lucero, Aparna Ramasubramanian","doi":"10.1080/08820538.2025.2450689","DOIUrl":"https://doi.org/10.1080/08820538.2025.2450689","url":null,"abstract":"<p><strong>Purpose: </strong>To examine propranolol efficacy in treating diffuse (DCH) and circumscribed choroidal hemangiomas (CCH) and controlling intraocular pressure (IOP) in patients with Sturge-Weber syndrome (SWS).</p><p><strong>Methods: </strong>A SWS patient case treated with propranolol for DCH is presented. Following PRISMA guidelines, we also performed a systematic review using PubMed/Web of Science, analyzing 14 studies detailing propranolol treatment outcomes for DCH, CCH, and IOP control in SWS. Demographic, clinical, treatment, and outcome data were extracted and statistically analyzed. Fisher's exact test was used to compare findings such as retinal detachment rates.</p><p><strong>Results: </strong>We reviewed patients treated with propranolol, including 8 DCH, 18 CCH, and 16 SWS cases of IOP control. Retinal detachment rates were significantly higher in DCH compared to CCH cases. Post-propranolol, 73% of DCH and CCH cases showed subretinal fluid improvement, and in SWS patients, 94% had IOP reduction.</p><p><strong>Conclusion: </strong>This study underscores the potential utility of propranolol beyond its traditional use in cutaneous hemangioma for treatment of CCH/DCH and IOP control.</p>","PeriodicalId":21702,"journal":{"name":"Seminars in Ophthalmology","volume":" ","pages":"1-9"},"PeriodicalIF":1.9,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Seminars in Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1